Sinopharm
1099.HK
#2060
Rank
โ‚น617.86 B
Marketcap
โ‚น197.99
Share price
-0.11%
Change (1 day)
-6.18%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.273 Trillion. an increase over the revenue in the year 2022 that were of โ‚น6.899 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 โ‚น7.273 T5.42%
2022 โ‚น6.899 T-2.1%
2021โ‚น7.047 T16.85%
2020โ‚น6.030 T14.95%
2019โ‚น5.246 T21.52%
2018โ‚น4.317 T5.93%
2017โ‚น4.075 T27.22%
2016โ‚น3.203 T5.37%
2015โ‚น3.040 T9.14%
2014โ‚น2.785 T17.22%
2013โ‚น2.376 T25.94%
2012โ‚น1.886 T34.61%
2011โ‚น1.401 T55.34%
2010โ‚น902.32 B35.79%
2009โ‚น664.51 B37.56%
2008โ‚น483.08 B31.43%
2007โ‚น367.56 B40.26%
2006โ‚น262.05 B